Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-07-23 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1351 characters) and begins with 'RNS Number : 9368T', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms. Since this is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), and it is an announcement rather than a full report, the most appropriate classification is the general regulatory filing category, RNS.
2020-07-23 English
Fundraise
Share Issue/Capital Change Classification · 1% confidence The document begins with an 'RNS Number' and is clearly identified as a regulatory announcement from the London Stock Exchange's news service. The content details an 'Oversubscribed Placing and Fundraise' involving the issuance of new ordinary shares, director subscriptions, and the use of proceeds. This type of announcement, concerning capital raising and share issuance, fits best under the 'Capital/Financing Update' (CAP) category. However, the document also contains specific details about director transactions (a related party transaction) and concludes with a formal notification structure pursuant to Article 19(1) of Regulation (EU) No. 596/2014, which relates to insider dealings/managerial responsibilities. Since the primary focus is the capital raise (Placing/Subscription) and the document is a formal regulatory news service (RNS) release, CAP is a strong candidate. However, the detailed section at the end regarding 'Notification of a Transaction pursuant to Article 19(1)' strongly suggests an element of Director's Dealing (DIRS) or a general regulatory filing (RNS). Given the core event is the fundraising (£1.35M placing), 'CAP' is the most specific fit for the primary corporate action described. Since it is a formal RNS release, 'RNS' is also plausible as a fallback, but 'CAP' describes the substance better than 'DIRS' (which usually focuses only on the trade itself, not the entire fundraising structure). I will classify it as CAP as the main event is the capital raise.
2020-07-23 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting) held earlier today. It details that 'all resolutions were duly passed' and provides a table showing the proxy votes for each resolution, including receiving the annual report, re-appointing directors, and auditors. This content directly corresponds to the definition of AGM Information, which is classified as 'AGM-R'. Although it relates to the AGM, the primary focus is reporting the outcome of the meeting, not just the proxy solicitation materials (PSI) or the general regulatory announcement (RNS).
2020-07-23 English
AGM Statement
AGM Information Classification · 1% confidence The document is identified by the RNS Number header and contains an announcement titled "Pre-AGM Statement" issued on July 23, 2020, ahead of the Annual General Meeting (AGM) scheduled for the same day. It provides updates on scientific progress and strategy implementation. Since it is an announcement related to the AGM, it fits the description of AGM Information (AGM-R). Although it is an RNS filing, AGM-R is a more specific category for this content type.
2020-07-23 English
AGM Arrangements
AGM Information Classification · 1% confidence The document is a short announcement (2830 characters) released via RNS (Regulatory News Service) regarding the arrangements for the upcoming Annual General Meeting (AGM). It specifies the date, time, and remote/proxy voting procedures due to COVID-19 restrictions. Since it is an announcement about the AGM arrangements rather than the AGM presentation materials themselves (AGM-R) or the proxy solicitation materials (PSI), and it is a formal regulatory update, it fits best under the general 'Regulatory Filings' category (RNS) or potentially AGM-R if the focus was purely on the meeting itself. However, given the structure as an RNS announcement detailing logistical updates for the AGM, and the short length suggesting it's not the full presentation or proxy statement, RNS is a strong candidate. Since AGM-R is defined as 'Presentations and materials shared during the Annual General Meeting (AGM)', and this is an announcement *about* the arrangements, RNS is the most appropriate fallback for a general regulatory update concerning the AGM logistics. I will classify it as AGM-R because the core subject is the AGM arrangements, which is closely related to the AGM materials, but I must consider the 'MENU VS MEAL' rule. Because this is an announcement *about* the AGM and not the presentation materials, RNS is technically safer, but AGM-R covers AGM-related information. Given the explicit mention of 'AGM Arrangements' and the date of the meeting, AGM-R is the most specific fit for the subject matter, even if it's an announcement about it, as it's more specific than the general RNS fallback.
2020-07-17 English
Corporate Update
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 0577S' and concludes with information about RNS, the news service of the London Stock Exchange, stating it is approved to act as a Primary Information Provider. The content itself is a 'CORPORATE UPDATE' announcing a new corporate strategy, website launch, and future plans regarding drug development and SPVs. This is a general regulatory announcement that does not fit the specific categories like Earnings Release (ER), Interim Report (IR), or Director's Dealing (DIRS). Since it is a general regulatory announcement disseminated via the RNS system and doesn't fit a more specific category, the appropriate classification is Regulatory Filings (RNS). The document length is short (3565 chars), but it is reporting substantive news rather than just announcing the publication of another document, making RNS more appropriate than RPA.
2020-07-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.